Literature DB >> 11254867

New prognostic factors for breast cancer recurrence.

C Isaacs1, V Stearns, D F Hayes.   

Abstract

Decisions regarding the use of adjuvant therapy for breast cancer are strongly influenced by the risk of disease recurrence and death. These risks are now determined by examining the currently recognized breast cancer prognostic factors including clinical stage, axillary nodal status, tumor size and grade, hormone receptor status, and presence of lymphovascular involvement. Newer factors are being evaluated in an attempt to more precisely define disease-related prognosis. This article provides an overview of issues that need to be considered when analyzing studies of prognostic factors, as well as a review of the currently recognized and the newer candidate prognostic factors.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11254867     DOI： 10.1016/s0093-7754(01)90045-4

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


  25 in total

Review 1.  Prognostic factors in breast cancer: current and new predictors of metastasis.

Authors:  D F Hayes; C Isaacs; V Stearns
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-10       Impact factor: 2.673

Review 2.  The promise of molecular profiling for cancer identification and treatment.

Authors:  Deanna Cross; James K Burmester
Journal:  Clin Med Res       Date:  2004-08

3.  Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer.

Authors:  Diana S M Buist; Linn A Abraham; William E Barlow; Arun Krishnaraj; Regan C Holdridge; Edward A Sickles; Patricia A Carney; Karla Kerlikowske; Berta M Geller
Journal:  Breast Cancer Res Treat       Date:  2010-08-11       Impact factor: 4.872

4.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.

Authors:  Howard Y Chang; Dimitry S A Nuyten; Julie B Sneddon; Trevor Hastie; Robert Tibshirani; Therese Sørlie; Hongyue Dai; Yudong D He; Laura J van't Veer; Harry Bartelink; Matt van de Rijn; Patrick O Brown; Marc J van de Vijver
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-08       Impact factor: 11.205

5.  Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer.

Authors:  Judith-Anne W Chapman; Daniel Meng; Lois Shepherd; Wendy Parulekar; James N Ingle; Hyman B Muss; Michael Palmer; Changhong Yu; Paul E Goss
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

6.  Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer.

Authors:  Zhi-Heng Huang; Xing-Song Tian; Rong Li; Xian-Ming Wang; Wen Wen; Hong Guan; Ya-Jie Yang
Journal:  Exp Ther Med       Date:  2011-11-28       Impact factor: 2.447

7.  c-myc amplifications in primary breast carcinomas and their local recurrences.

Authors:  S Aulmann; N Adler; J Rom; B Helmchen; P Schirmacher; H P Sinn
Journal:  J Clin Pathol       Date:  2006-02-23       Impact factor: 3.411

8.  Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.

Authors:  Ben S Wittner; Dennis C Sgroi; Paula D Ryan; Tako J Bruinsma; Annuska M Glas; Anitha Male; Sonika Dahiya; Karleen Habin; Rene Bernards; Daniel A Haber; Laura J Van't Veer; Sridhar Ramaswamy
Journal:  Clin Cancer Res       Date:  2008-05-15       Impact factor: 12.531

9.  Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer.

Authors:  Patrick Neven; Giuseppe Floris; Laurence Slembrouck; Isabelle Vanden Bempt; Hans Wildiers; Ann Smeets; Anne-Sophie Van Rompuy; Chantal Van Ongeval; Lynn Jongen; Caroline Weltens; Kevin Punie; Griet Hoste; Els Van Nieuwenhuysen; Sileny Han; Ines Nevelsteen
Journal:  Mod Pathol       Date:  2021-02-08       Impact factor: 7.842

10.  Clinical impact of PTEN methylation status as a prognostic marker for breast cancer.

Authors:  Amal Ramadan; Maha Hashim; Amr Abouzid; Menha Swellam
Journal:  J Genet Eng Biotechnol       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.